Roof and floor of the muscarinic binding pocket: Variations in the binding modes of orthosteric ligands

被引:35
作者
Goodwin, J. Alex
Hulme, Edward C.
Langmead, Christopher J.
Tehan, Ben G.
机构
[1] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England
[2] GlaxoSmithKline, Harlow, Essex, England
基金
英国医学研究理事会;
关键词
D O I
10.1124/mol.107.038265
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alanine substitution mutagenesis has been used to investigate residues that make up the roof and floor of the muscarinic binding pocket and regulate ligand access. We mutated the amino acids in the second extracellular loop of the M-1 muscarinic acetylcholine receptor that are homologous to the cis-retinal contact residues in rhodopsin, the disulfide-bonded Cys178 and Cys98 that anchor the loop to transmembrane helix 3, the adjoining acidic residue Asp99, and the conserved aromatic residues Phe197 and Trp378 in the transmembrane domain. The effects on ligand binding, kinetics, and receptor function suggest that the second extracellular loop does not provide primary contacts for orthosteric ligands, including acetylcholine, but that it does contribute to microdomains that are important for the conformational changes that accompany receptor activation. Kinetic studies suggest that the disulfide bond between Cys98 and Cys178 may contribute to structures that regulate the access of positively charged ligands such as N-methyl scopolamine to the binding pocket. Asp99 may act as a gatekeeper residue to this channel. In contrast, the bulkier lipophilic ligand 3-quinuclidinyl benzilate may require breathing motions of the receptor to access the binding site. Trp378 is a key residue for receptor activation as well as binding, whereas Phe197 represents the floor of the N-methyl scopolamine binding pocket but does not interact with acetylcholine or 3-quinuclidinyl benzilate. Differences between the binding modes of N-methyl scopolamine, 3-quinuclidinyl benzilate, and acetylcholine have been modeled. Although the head groups of these ligands occupy overlapping volumes within the binding site, their side chains may follow significantly different directions.
引用
收藏
页码:1484 / 1496
页数:13
相关论文
共 41 条
[1]   Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M1 muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine [J].
Allman, K ;
Page, KM ;
Curtis, CAM ;
Hulme, EC .
MOLECULAR PHARMACOLOGY, 2000, 58 (01) :175-184
[2]   A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell [J].
Azpiazu, I ;
Gautam, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27709-27718
[3]  
Ballasteros J. A., 1995, Methods in neurosciences, V25, P366
[4]   Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists [J].
Blaney, FE ;
Raveglia, LF ;
Artico, M ;
Cavagnera, S ;
Dartois, C ;
Farina, C ;
Grugni, M ;
Gagliardi, S ;
Luttmann, MA ;
Martinelli, M ;
Nadler, GMMG ;
Parini, C ;
Petrillo, P ;
Sarau, HM ;
Scheideler, MA ;
Hay, DWP ;
Giardina, GAM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) :1675-1689
[5]  
BLANEY FE, 2006, CURRENT PROTOCOLS PH, V9
[6]   Modelling of the binding site of the human m(1) muscarinic receptor: Experimental validation and refinement [J].
Bourdon, H ;
TrumppKallmeyer, S ;
Schreuder, H ;
Hoflack, J ;
Hibert, M ;
Wermuth, CG .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (04) :317-332
[7]   BACKBONE-DEPENDENT ROTAMER LIBRARY FOR PROTEINS - APPLICATION TO SIDE-CHAIN PREDICTION [J].
DUNBRACK, RL ;
KARPLUS, M .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (02) :543-574
[8]  
FRASER CM, 1989, MOL PHARMACOL, V36, P840
[9]   Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors [J].
Gnagey, AL ;
Seidenberg, M ;
Ellis, J .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1245-1253
[10]   Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site [J].
Heitz, F ;
Holzwarth, JA ;
Gies, JP ;
Pruss, RM ;
Trumpp-Kallmeyer, S ;
Hibert, MF ;
Guenet, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 380 (2-3) :183-195